American Podiatric Medical Licensing Examination (APMLE) Part 2 Practice Test

Combining results from multiple randomized trials in a meta-analysis provides the highest level of clinical evidence for comparing therapies. Randomization limits confounding, and pooling data across several high-quality trials increases the total sample size, sharpened precision, and power to detect a real difference. It also lets us examine whether the treatment effect is consistent across different populations, settings, and study designs, which enhances generalizability. A multicenter randomized trial is indeed strong because it randomizes participants across multiple sites, reducing site-specific biases, but it represents a single study. A meta-analysis, by synthesizing several such trials, often yields a more reliable and precise estimate of the comparative effect than any individual trial. The other options involve nonrandomized or descriptive designs that are more prone to bias and confounding, providing weaker evidence for treatment comparisons.